EUVIMEDOpdag EUVIMED
Crossref

Fe‐EGCG Nanozymes Ameliorate Erectile Dysfunction Induced by Cavernous Nerve Injury Through Inhibition of Oxidative Stress

Zhiyue Wu, Jiayin Hu, Zhenbo Wang, Yuanyuan Wu, Anyu Xia, Qi Zhang, Keli Xu, Runnan Xu iD, Wenjie Huang, Xiaojun Huang, Bodong Lv

Andrology · 2026-05-28

DOI: 10.1111/andr.70269 ↗

At a glance

Journal article in Andrology, published online on 2026-05-28. Written by Zhiyue Wu and 10 co-authors. Institution: Department of Urology, The Second Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China. 47 references. Funded by: National Natural Science Foundation of China, Jinhua Science and Technology Bureau.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Cavernous nerve injury‐induced erectile dysfunction (CNI‐ED) is a common postoperative complication of pelvic surgery that currently lacks effective treatments. Oxidative stress (OS) plays a central role in its pathogenesis. Although epigallocatechin gallate (EGCG) has demonstrated antioxidant properties, its clinical application is limited by poor stability and bioavailability. Iron‐EGCG nanozymes (Fe‐EGCG), which integrate the enzymatic properties of nanoparticles with the antioxidant characteristics of EGCG through metal‐polyphenol coordination, may provide a superior solution for restoring oxidative stress balance.

Objective

To investigate the therapeutic effects and underlying mechanisms of Fe‐EGCG in ameliorating CNI‐ED. Materials and Methods Fe‐EGCG was synthesized via metal‐polyphenol coordination and characterized for morphology and catalytic activity. Its reactive oxygen species (ROS) scavenging capacity was verified in vitro using PC‐12 cells. Twenty‐four rats were randomly assigned to four groups: sham‐operated, bilateral cavernous nerve injury (BCNI), BCNI + EGCG, and BCNI + Fe‐EGCG. EGCG and Fe‐EGCG (100 µL, 2 mg/mL) were locally injected at the cavernous nerve injury site. Three weeks post‐treatment, erectile function was evaluated. Cavernous nerves and penile tissues were collected for ultrastructural, histological, and molecular biological analyses.

Results

Fe‐EGCG nanozymes were successfully synthesized and characterized. In vitro experiments demonstrated that Fe‐EGCG exhibited significantly stronger superoxide dismutase (SOD) and catalase (CAT) activities, as well as superior ROS scavenging capacity, compared to EGCG. In vivo studies further revealed that Fe‐EGCG achieved better therapeutic outcomes than EGCG. Compared with the BCNI group, both EGCG and Fe‐EGCG treatments significantly alleviated neural damage. This effect was evidenced by increased axonal density, enhanced Schwann cell proliferation, and restoration of neuronal nitric oxide synthase (nNOS) expression. Additionally, erectile function was significantly improved in both treatment groups. The BCNI rats exhibited decreased smooth muscle content, increased collagen deposition in the corpus cavernosum, and upregulated fibrosis markers, all of which were significantly attenuated following EGCG and Fe‐EGCG administration. Mechanistically, both treatments reduced oxidative stress levels and were associated with upregulation of the Nrf2/HO‐1 pathway and downregulation of NLRP3 inflammasome activity. Discussion and Conclusion Fe‐EGCG ameliorates CNI‐ED by attenuating oxidative stress, protecting nerves, and inhibiting penile fibrosis. This study establishes Fe‐EGCG as a novel and promising therapeutic strategy for CNI‐ED. As a nanozyme self‐assembled from metal ions and natural organic ligands, it enhances the efficacy of traditional antioxidants through synergistic effects.

Subjects

Author keywords

Fe‐EGCG nanozymesNrf2/HO‐1 pathwaycavernous nerve injuryepigallocatechin gallateerectile dysfunctionoxidative stress

Authors and institutions

  • Department of Urology, The Second Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China.
  • Center for Medical Research and Innovation in Digestive System Tumors, Ministry of Education, Hangzhou, China.
  • The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

ORCID profiles: Runnan Xu

Funding

  • National Natural Science Foundation of China
  • Jinhua Science and Technology Bureau

Cite

APA

Wu, Z., Hu, J., Wang, Z., Wu, Y., Xia, A., Zhang, Q., Xu, K., Xu, R., Huang, W., Huang, X., & Lv, B. (2026). Fe‐EGCG Nanozymes Ameliorate Erectile Dysfunction Induced by Cavernous Nerve Injury Through Inhibition of Oxidative Stress. Andrology. https://doi.org/10.1111/andr.70269

Vancouver

Wu Z, Hu J, Wang Z, Wu Y, Xia A, Zhang Q, et al. Fe‐EGCG Nanozymes Ameliorate Erectile Dysfunction Induced by Cavernous Nerve Injury Through Inhibition of Oxidative Stress. Andrology. 2026. doi:10.1111/andr.70269

BibTeX
@article{Wu2026,
  author = {Wu, Zhiyue and Hu, Jiayin and Wang, Zhenbo and Wu, Yuanyuan and Xia, Anyu and Zhang, Qi and Xu, Keli and Xu, Runnan and Huang, Wenjie and Huang, Xiaojun and Lv, Bodong},
  title = {Fe‐EGCG Nanozymes Ameliorate Erectile Dysfunction Induced by Cavernous Nerve Injury Through Inhibition of Oxidative Stress},
  journal = {Andrology},
  year = {2026},
  doi = {10.1111/andr.70269}
}
Start for free →